Recipharm Adds Sterile Semi-Solid Manufacturing Capacity at Portuguese Site
Key Points
- New sterile cream and ointment line at Odivelas, Portugal, with annual capacity of 8 million to 15 million units depending on batch size and fill volume.
- The line accommodates aluminum and polyfoil tubes from 3.5g to 30g and handles ophthalmic products.
- The addition builds on the site's existing sterile ophthalmic manufacturing, broadening its sterile product portfolio under a shared quality system.
Recipharm has expanded its sterile manufacturing capabilities with a new cream and ointment production line at its Odivelas facility in Portugal, increasing options for pharmaceutical companies seeking contract manufacturing support for sterile semi-solid products. The new line is designed to handle a range of applications, including ophthalmic products, and is expected to produce between 8 million and 15 million units annually. Production capacity will vary depending on batch size and fill volume.
The equipment accommodates both aluminum and polyfoil tubes in formats ranging from 3.5g to 30g, giving customers flexibility to select packaging suited to their formulations and target markets. The line is now available to support new customer projects.
Sterile creams and ointments require specialized manufacturing controls, making access to appropriate production infrastructure an important consideration for pharmaceutical developers. At Odivelas, the addition builds on the site’s existing sterile ophthalmic manufacturing capabilities, broadening the range of sterile products that can be produced at the facility.
According to Recipharm CEO Greg Behar, the investment is intended to give customers additional manufacturing capacity and packaging options while supporting a more streamlined supply chain. By bringing sterile semi-solid production together with its established multidose ophthalmic line, Recipharm aims to offer customers access to a wider portfolio of sterile products at a single site, operating under a shared quality system and supported by the same teams.
For more information, visit www.recipharm.com.
Total Page Views: 10
